LMR Partners’s Merck MRK Stock Holding History

LMR Partners’s Portfolio MRK Stock Details MRK Fund Activity

Bought

Maintained

Sold

Quarter	Market Value	Status	Shares	Change in Stake	Trade Value	Portfolio Weight	Portfolio Position
2025 Q1	–	Sell	-15,000	Closed	-$1.49M	–	1550
2024 Q4	$1.49M	Hold	15,000	–	–	0.01%	672
2024 Q3	$1.7M	Buy	+15,000	New	+$1.78M	0.01%	647

Other funds holding MRK

BlackRock New York $6.73T AUM 46.02% 1-Year Est. Return

Vanguard Capital Management Malvern, Pennsylvania $4.68T AUM

State Street Boston, Massachusetts $3.37T AUM 44.26% 1-Year Est. Return

Wellington Management Group Boston, Massachusetts $580B AUM 38.23% 1-Year Est. Return

Vanguard Portfolio Management Malvern, Pennsylvania $2.22T AUM

Geode Capital Management Boston, Massachusetts $1.88T AUM 44.46% 1-Year Est. Return

Charles Schwab San Francisco, California $751B AUM 38.74% 1-Year Est. Return

Morgan Stanley New York $1.89T AUM 35.08% 1-Year Est. Return

Fidelity Investments Boston, Massachusetts $2.3T AUM 54.33% 1-Year Est. Return

JP Morgan Chase New York $1.81T AUM 41.13% 1-Year Est. Return

LMR Partners's MRK Position: Q2 2026 in Review

LMR Partners increased its Merck (MRK) stake by 1,368% in Q2 2026, buying an estimated $4.8M and bringing the position to 44,030 shares worth $5.66M. The position accounts for 0.02% of the portfolio, ranked #596.

LMR Partners first reported a position in MRK in Q2 2014 and has held it in 19 quarters since. 3,833 funds tracked by Wall St. Rank hold MRK as of Q2 2026.

LMR Partners held 44,030 shares of Merck worth $5.66M as of Q2 2026.
LMR Partners bought 41,030 Merck shares in Q2 2026, an estimated $4.8M.
Merck made up 0.02% of LMR Partners's portfolio in Q2 2026, its #596 holding.
LMR Partners first reported a position in Merck in Q2 2014 and has held it in 19 quarters since.
3,833 funds tracked by Wall St. Rank held Merck as of Q2 2026.

Based on LMR Partners's 13F filing for Q2 2026, filed 14 Aug 2026.